Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 3,977 filings

Top spenders & firms Spend by issue

Clear
Q1
DUANE MORRIS GOVERNMENT STRATEGIES for JEFFERSON MOSS-MAGEE REHABILITATION HOSPITAL
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $10,000.00 income
Health Issues
View →
Q1
APCO WORLDWIDE LLC for HIKMA PHARMACEUTICALS USA INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $30,000.00 income
Health Issues, Trade (domestic/foreign)
View →
Q1
BELL & LINDSAY, INC. for PROMEDTEK, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Arizona · House · Senate · $40,000.00 income
Health Issues
View →
Q1
EHEALTH, INC. for EHEALTH, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate
Health Issues
View →
Q1
BOCKORNY GROUP, INC. for THE EVANGELICAL LUTHERAN GOOD SAMARITAN SOCIETY
1st Quarter (Jan 1 - Mar 31) 2026 · South Dakota · House · Senate · $40,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
INVARIANT LLC for OURARING INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $80,000.00 income
Health Issues, Copyright/Patent/Trademark
View →
Q1
HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY for HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View →
RR
AVIVA STRATEGIES (FKA MGB CONSULTING) for ARPA-H GO
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia
Health Issues
View →
Q1
COZEN O'CONNOR PUBLIC STRATEGIES for AMERICAN BOARD OF MEDICAL SPECIALTIES
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $50,000.00 income
Health Issues
View →
Q1
COZEN O'CONNOR PUBLIC STRATEGIES for AMERICAN ASSOCIATION OF ORTHODONTISTS
1st Quarter (Jan 1 - Mar 31) 2026 · Missouri · House · Senate · $50,000.00 income
Health Issues, Education
View →
Q1
MICHIGAN HEALTH & HOSPITAL ASSOCIATION for MICHIGAN HEALTH & HOSPITAL ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · Michigan · House
Health Issues
View →
Q1
DLA PIPER LLP (US) for BIOHAVEN PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Connecticut · House · Senate · $60,000.00 income
Health Issues
View →
Q1
CONTINENTAL STRATEGY, LLC for MUSCULO, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Florida · House · Senate · $22,904.00 income
Health Issues
View →
1T
AVIVA STRATEGIES (FKA MGB CONSULTING) for ULTRAGENYX PHARMACEUTICAL
1st Quarter (Jan 1 - Mar 31) 2026 · California
Health Issues
View →
Q1
VANTIVE US HEALTHCARE LLC for VANTIVE US HEALTHCARE LLC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Foreign Relations, Trade (domestic/foreign)
View →
Q1
H&M STRATEGIES LLP for AARP
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $30,000.00 income
Health Issues, Telecommunications, Taxation/Internal Revenue Code
View →
Q1
AVIVA STRATEGIES (FKA MGB CONSULTING) for ACT FOR ULTRA RARE
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · $37,500.00 income
Health Issues
View →
Q1
PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues
View →
Q1
ALKERMES, INC. for ALKERMES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate
Medicare/Medicaid, Health Issues, Alcohol and Drug Abuse, Tariff (miscellaneous tariff bills)
View →
Q1
TENAGRITY SOLUTIONS, LLC for KARDIOGENICS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate
Defense, Medical/Disease Research/Clinical Labs, Health Issues, Budget/Appropriations
View →
Q1
COZEN O'CONNOR PUBLIC STRATEGIES for AMERICAN ACADEMY OF FAMILY PHYSICIANS
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $60,000.00 income
Health Issues
View →
Q1
COZEN O'CONNOR PUBLIC STRATEGIES for AGILITI HEALTH INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Minnesota · House · Senate · $50,000.00 income
Health Issues
View →
Q1
NOSSAMAN LLP for NEUROFLOW
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $20,000.00 income
Health Issues
View →
Q1
ACG ADVOCACY for ELEKTA INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Georgia · House · Senate · $20,000.00 income
Health Issues, Trade (domestic/foreign), Medicare/Medicaid
View →
Q1
FRONTLINE GOVERNMENT RELATIONS for EMPOWER PHARMACY
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate
Health Issues, Manufacturing
View →
Previous Page 84 of 160 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem